Engagement within the new system
Upcoming SlideShare
Loading in...5
×
 

Engagement within the new system

on

  • 576 views

 

Statistics

Views

Total Views
576
Views on SlideShare
146
Embed Views
430

Actions

Likes
0
Downloads
1
Comments
0

5 Embeds 430

http://www.pmsociety.org.uk 389
http://pmsociety.org.uk 38
http://webcache.googleusercontent.com 1
http://www.google.co.uk 1
http://www.google.com 1

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Engagement within the new system Engagement within the new system Presentation Transcript

  • Engagement within the new system Paul McManus, Lead Pharmacist | Specialised Commissioning
  • Engagement within the new system Paul McManus Lead pharmacist - specialised services South Yorkshire and Bassetlaw Area Team ABPI Regional event June 2013
  • NHS | Presentation to [XXXX Company] | [Type Date]3
  • Opportunities for engagement Product specific National • research • pipeline • commissioning • value • price • placement 4 Local • implementation • price • priorities • problems
  • Medicines optimisation Medicines still most common therapeutic intervention and biggest cost after staff, but, for example: • 30 to 50% not taken as intended • Patients have insufficient supporting information • UK Literature suggests 5 to 8% of hospital admissions due to preventable adverse effects of medicines • Medication errors across all sectors and age groups at unacceptable levels • Medicines wastage in primary care: £300M pa with £150M pa avoidable • Relatively little effort towards understanding clinical effectiveness of medicines in real practice • The threat of antimicrobial resistance
  • National Reporting and Learning System for England and Wales Types of incidents 2005-10 Cousins D, Gerrett D, Warner B. Br J Clin Pharmacol. 2012
  • NRLS in England and Wales medication incident reports 2005 - 10 Cousins D, Gerrett D, Warner B. Br J Clin Pharmacol. 2012
  • NRLS – who is reporting incidents? 8 Cousins D, Gerrett D, Warner B. Br J Clin Pharmacol. 2012
  • NRLS – Critical medicines Cousins D, Gerrett D, Warner B. Br J Clin Pharmacol. 2012 NRLS – Critical medicines
  • NRLS – Error category Cousins D, Gerrett D, Warner B. Br J Clin Pharmacol. 2012
  • Medicines Optimisation Principles
  • A strategy might include… • Patient engagement • Collaborative working across health economies • Improving outcomes • Value for money • Partnership with industry • Medicines pathway • Safety and assurance 12 Information and technology
  • What can we do? • Be an active commissioner • Ensure contact at right level and make meetings productive for all • Look for ways to best use skills and resources available • Think beyond individual products • Start talking 13
  • Engagement within the new system paulmcmanus@nhs.net 14